Medical Care
Global Crohn’s Disease Therapeutics Market Research Report 2025
- Sep 09, 25
- ID: 494485
- Pages: 90
- Figures: 89
- Views: 19
This report aims to provide a comprehensive presentation of the global market for Crohn’s Disease Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crohn’s Disease Therapeutics.
The Crohn’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Segment by Type
Non-Surgical
Surgical
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Crohn’s Disease Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crohn’s Disease Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crohn’s Disease Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson and Johnson Services Inc.
Pfizer Inc.
Allergan
AbbVie Inc.
Takeda Pharmaceutical Company Limited
Celgene Corporation
Perrigo Company PLC
Ferring B.V.
Salix Pharmaceuticals
Gilead Sciences Inc.
Genentech Inc.
UCB India Private Limited.
Segment by Type
Non-Surgical
Surgical
Segment by Application
Hospitals
Ambulatory Surgical Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crohn’s Disease Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-Surgical
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Crohn’s Disease Therapeutics Growth Trends by Region
2.2.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Crohn’s Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Crohn’s Disease Therapeutics Market Dynamics
2.3.1 Crohn’s Disease Therapeutics Industry Trends
2.3.2 Crohn’s Disease Therapeutics Market Drivers
2.3.3 Crohn’s Disease Therapeutics Market Challenges
2.3.4 Crohn’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Crohn’s Disease Therapeutics Revenue
3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Crohn’s Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Crohn’s Disease Therapeutics, Product and Application
3.7 Global Key Players of Crohn’s Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type
4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Crohn’s Disease Therapeutics Breakdown Data by Application
5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Crohn’s Disease Therapeutics Market Size (2020-2031)
6.2 North America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Therapeutics Market Size (2020-2031)
7.2 Europe Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Details
11.1.2 Johnson and Johnson Services Inc. Business Overview
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.1.5 Johnson and Johnson Services Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.2.5 Pfizer Inc. Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.3.5 Allergan Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Details
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.4.5 AbbVie Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Details
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.6.5 Celgene Corporation Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Details
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.7.5 Perrigo Company PLC Recent Development
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Details
11.8.2 Ferring B.V. Business Overview
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.8.5 Ferring B.V. Recent Development
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Details
11.9.2 Salix Pharmaceuticals Business Overview
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.9.5 Salix Pharmaceuticals Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Details
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.10.5 Gilead Sciences Inc. Recent Development
11.11 Genentech Inc.
11.11.1 Genentech Inc. Company Details
11.11.2 Genentech Inc. Business Overview
11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
11.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.11.5 Genentech Inc. Recent Development
11.12 UCB India Private Limited.
11.12.1 UCB India Private Limited. Company Details
11.12.2 UCB India Private Limited. Business Overview
11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
11.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.12.5 UCB India Private Limited. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Non-Surgical
1.2.3 Surgical
1.3 Market by Application
1.3.1 Global Crohn’s Disease Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crohn’s Disease Therapeutics Market Perspective (2020-2031)
2.2 Global Crohn’s Disease Therapeutics Growth Trends by Region
2.2.1 Global Crohn’s Disease Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Crohn’s Disease Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Crohn’s Disease Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Crohn’s Disease Therapeutics Market Dynamics
2.3.1 Crohn’s Disease Therapeutics Industry Trends
2.3.2 Crohn’s Disease Therapeutics Market Drivers
2.3.3 Crohn’s Disease Therapeutics Market Challenges
2.3.4 Crohn’s Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crohn’s Disease Therapeutics Players by Revenue
3.1.1 Global Top Crohn’s Disease Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Crohn’s Disease Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Crohn’s Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Crohn’s Disease Therapeutics Revenue
3.4 Global Crohn’s Disease Therapeutics Market Concentration Ratio
3.4.1 Global Crohn’s Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crohn’s Disease Therapeutics Revenue in 2024
3.5 Global Key Players of Crohn’s Disease Therapeutics Head office and Area Served
3.6 Global Key Players of Crohn’s Disease Therapeutics, Product and Application
3.7 Global Key Players of Crohn’s Disease Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Crohn’s Disease Therapeutics Breakdown Data by Type
4.1 Global Crohn’s Disease Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2026-2031)
5 Crohn’s Disease Therapeutics Breakdown Data by Application
5.1 Global Crohn’s Disease Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Crohn’s Disease Therapeutics Market Size (2020-2031)
6.2 North America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
6.4 North America Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crohn’s Disease Therapeutics Market Size (2020-2031)
7.2 Europe Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
7.4 Europe Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crohn’s Disease Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Crohn’s Disease Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crohn’s Disease Therapeutics Market Size (2020-2031)
9.2 Latin America Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crohn’s Disease Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Crohn’s Disease Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson and Johnson Services Inc.
11.1.1 Johnson and Johnson Services Inc. Company Details
11.1.2 Johnson and Johnson Services Inc. Business Overview
11.1.3 Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Introduction
11.1.4 Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.1.5 Johnson and Johnson Services Inc. Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Crohn’s Disease Therapeutics Introduction
11.2.4 Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.2.5 Pfizer Inc. Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Crohn’s Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.3.5 Allergan Recent Development
11.4 AbbVie Inc.
11.4.1 AbbVie Inc. Company Details
11.4.2 AbbVie Inc. Business Overview
11.4.3 AbbVie Inc. Crohn’s Disease Therapeutics Introduction
11.4.4 AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.4.5 AbbVie Inc. Recent Development
11.5 Takeda Pharmaceutical Company Limited
11.5.1 Takeda Pharmaceutical Company Limited Company Details
11.5.2 Takeda Pharmaceutical Company Limited Business Overview
11.5.3 Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Introduction
11.5.4 Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.5.5 Takeda Pharmaceutical Company Limited Recent Development
11.6 Celgene Corporation
11.6.1 Celgene Corporation Company Details
11.6.2 Celgene Corporation Business Overview
11.6.3 Celgene Corporation Crohn’s Disease Therapeutics Introduction
11.6.4 Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.6.5 Celgene Corporation Recent Development
11.7 Perrigo Company PLC
11.7.1 Perrigo Company PLC Company Details
11.7.2 Perrigo Company PLC Business Overview
11.7.3 Perrigo Company PLC Crohn’s Disease Therapeutics Introduction
11.7.4 Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.7.5 Perrigo Company PLC Recent Development
11.8 Ferring B.V.
11.8.1 Ferring B.V. Company Details
11.8.2 Ferring B.V. Business Overview
11.8.3 Ferring B.V. Crohn’s Disease Therapeutics Introduction
11.8.4 Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.8.5 Ferring B.V. Recent Development
11.9 Salix Pharmaceuticals
11.9.1 Salix Pharmaceuticals Company Details
11.9.2 Salix Pharmaceuticals Business Overview
11.9.3 Salix Pharmaceuticals Crohn’s Disease Therapeutics Introduction
11.9.4 Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.9.5 Salix Pharmaceuticals Recent Development
11.10 Gilead Sciences Inc.
11.10.1 Gilead Sciences Inc. Company Details
11.10.2 Gilead Sciences Inc. Business Overview
11.10.3 Gilead Sciences Inc. Crohn’s Disease Therapeutics Introduction
11.10.4 Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.10.5 Gilead Sciences Inc. Recent Development
11.11 Genentech Inc.
11.11.1 Genentech Inc. Company Details
11.11.2 Genentech Inc. Business Overview
11.11.3 Genentech Inc. Crohn’s Disease Therapeutics Introduction
11.11.4 Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.11.5 Genentech Inc. Recent Development
11.12 UCB India Private Limited.
11.12.1 UCB India Private Limited. Company Details
11.12.2 UCB India Private Limited. Business Overview
11.12.3 UCB India Private Limited. Crohn’s Disease Therapeutics Introduction
11.12.4 UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2020-2025)
11.12.5 UCB India Private Limited. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-Surgical
Table 3. Key Players of Surgical
Table 4. Global Crohn’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Crohn’s Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Crohn’s Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Crohn’s Disease Therapeutics Market Share by Region (2020-2025)
Table 8. Global Crohn’s Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Crohn’s Disease Therapeutics Market Share by Region (2026-2031)
Table 10. Crohn’s Disease Therapeutics Market Trends
Table 11. Crohn’s Disease Therapeutics Market Drivers
Table 12. Crohn’s Disease Therapeutics Market Challenges
Table 13. Crohn’s Disease Therapeutics Market Restraints
Table 14. Global Crohn’s Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Crohn’s Disease Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2024)
Table 17. Ranking of Global Top Crohn’s Disease Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Crohn’s Disease Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Crohn’s Disease Therapeutics, Product and Application
Table 21. Global Key Players of Crohn’s Disease Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Crohn’s Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Crohn’s Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Johnson and Johnson Services Inc. Company Details
Table 47. Johnson and Johnson Services Inc. Business Overview
Table 48. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product
Table 49. Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Johnson and Johnson Services Inc. Recent Development
Table 51. Pfizer Inc. Company Details
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Crohn’s Disease Therapeutics Product
Table 54. Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Pfizer Inc. Recent Development
Table 56. Allergan Company Details
Table 57. Allergan Business Overview
Table 58. Allergan Crohn’s Disease Therapeutics Product
Table 59. Allergan Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Allergan Recent Development
Table 61. AbbVie Inc. Company Details
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. Crohn’s Disease Therapeutics Product
Table 64. AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. Takeda Pharmaceutical Company Limited Company Details
Table 67. Takeda Pharmaceutical Company Limited Business Overview
Table 68. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product
Table 69. Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Takeda Pharmaceutical Company Limited Recent Development
Table 71. Celgene Corporation Company Details
Table 72. Celgene Corporation Business Overview
Table 73. Celgene Corporation Crohn’s Disease Therapeutics Product
Table 74. Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Celgene Corporation Recent Development
Table 76. Perrigo Company PLC Company Details
Table 77. Perrigo Company PLC Business Overview
Table 78. Perrigo Company PLC Crohn’s Disease Therapeutics Product
Table 79. Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Perrigo Company PLC Recent Development
Table 81. Ferring B.V. Company Details
Table 82. Ferring B.V. Business Overview
Table 83. Ferring B.V. Crohn’s Disease Therapeutics Product
Table 84. Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Ferring B.V. Recent Development
Table 86. Salix Pharmaceuticals Company Details
Table 87. Salix Pharmaceuticals Business Overview
Table 88. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product
Table 89. Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Salix Pharmaceuticals Recent Development
Table 91. Gilead Sciences Inc. Company Details
Table 92. Gilead Sciences Inc. Business Overview
Table 93. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product
Table 94. Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Gilead Sciences Inc. Recent Development
Table 96. Genentech Inc. Company Details
Table 97. Genentech Inc. Business Overview
Table 98. Genentech Inc. Crohn’s Disease Therapeutics Product
Table 99. Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Genentech Inc. Recent Development
Table 101. UCB India Private Limited. Company Details
Table 102. UCB India Private Limited. Business Overview
Table 103. UCB India Private Limited. Crohn’s Disease Therapeutics Product
Table 104. UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 105. UCB India Private Limited. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Crohn’s Disease Therapeutics Picture
Figure 2. Global Crohn’s Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Crohn’s Disease Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Non-Surgical Features
Figure 5. Surgical Features
Figure 6. Global Crohn’s Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Crohn’s Disease Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Crohn’s Disease Therapeutics Report Years Considered
Figure 11. Global Crohn’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Crohn’s Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Crohn’s Disease Therapeutics Market Share by Region: 2024 VS 2031
Figure 14. Global Crohn’s Disease Therapeutics Market Share by Players in 2024
Figure 15. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Crohn’s Disease Therapeutics Revenue in 2024
Figure 17. North America Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 19. United States Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 23. Germany Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Crohn’s Disease Therapeutics Market Share by Region (2020-2031)
Figure 31. China Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 39. Mexico Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 43. Turkey Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Johnson and Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 47. Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 48. Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 49. AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 50. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 51. Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 52. Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 53. Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 54. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 55. Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 56. Genentech Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 57. UCB India Private Limited. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Crohn’s Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Non-Surgical
Table 3. Key Players of Surgical
Table 4. Global Crohn’s Disease Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Crohn’s Disease Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Crohn’s Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Crohn’s Disease Therapeutics Market Share by Region (2020-2025)
Table 8. Global Crohn’s Disease Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Crohn’s Disease Therapeutics Market Share by Region (2026-2031)
Table 10. Crohn’s Disease Therapeutics Market Trends
Table 11. Crohn’s Disease Therapeutics Market Drivers
Table 12. Crohn’s Disease Therapeutics Market Challenges
Table 13. Crohn’s Disease Therapeutics Market Restraints
Table 14. Global Crohn’s Disease Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Crohn’s Disease Therapeutics Market Share by Players (2020-2025)
Table 16. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2024)
Table 17. Ranking of Global Top Crohn’s Disease Therapeutics Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Crohn’s Disease Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Crohn’s Disease Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Crohn’s Disease Therapeutics, Product and Application
Table 21. Global Key Players of Crohn’s Disease Therapeutics, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Crohn’s Disease Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2020-2025)
Table 25. Global Crohn’s Disease Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Crohn’s Disease Therapeutics Revenue Market Share by Type (2026-2031)
Table 27. Global Crohn’s Disease Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2020-2025)
Table 29. Global Crohn’s Disease Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Crohn’s Disease Therapeutics Revenue Market Share by Application (2026-2031)
Table 31. North America Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Crohn’s Disease Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Crohn’s Disease Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Crohn’s Disease Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Crohn’s Disease Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Johnson and Johnson Services Inc. Company Details
Table 47. Johnson and Johnson Services Inc. Business Overview
Table 48. Johnson and Johnson Services Inc. Crohn’s Disease Therapeutics Product
Table 49. Johnson and Johnson Services Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 50. Johnson and Johnson Services Inc. Recent Development
Table 51. Pfizer Inc. Company Details
Table 52. Pfizer Inc. Business Overview
Table 53. Pfizer Inc. Crohn’s Disease Therapeutics Product
Table 54. Pfizer Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 55. Pfizer Inc. Recent Development
Table 56. Allergan Company Details
Table 57. Allergan Business Overview
Table 58. Allergan Crohn’s Disease Therapeutics Product
Table 59. Allergan Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Allergan Recent Development
Table 61. AbbVie Inc. Company Details
Table 62. AbbVie Inc. Business Overview
Table 63. AbbVie Inc. Crohn’s Disease Therapeutics Product
Table 64. AbbVie Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 65. AbbVie Inc. Recent Development
Table 66. Takeda Pharmaceutical Company Limited Company Details
Table 67. Takeda Pharmaceutical Company Limited Business Overview
Table 68. Takeda Pharmaceutical Company Limited Crohn’s Disease Therapeutics Product
Table 69. Takeda Pharmaceutical Company Limited Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 70. Takeda Pharmaceutical Company Limited Recent Development
Table 71. Celgene Corporation Company Details
Table 72. Celgene Corporation Business Overview
Table 73. Celgene Corporation Crohn’s Disease Therapeutics Product
Table 74. Celgene Corporation Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Celgene Corporation Recent Development
Table 76. Perrigo Company PLC Company Details
Table 77. Perrigo Company PLC Business Overview
Table 78. Perrigo Company PLC Crohn’s Disease Therapeutics Product
Table 79. Perrigo Company PLC Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Perrigo Company PLC Recent Development
Table 81. Ferring B.V. Company Details
Table 82. Ferring B.V. Business Overview
Table 83. Ferring B.V. Crohn’s Disease Therapeutics Product
Table 84. Ferring B.V. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Ferring B.V. Recent Development
Table 86. Salix Pharmaceuticals Company Details
Table 87. Salix Pharmaceuticals Business Overview
Table 88. Salix Pharmaceuticals Crohn’s Disease Therapeutics Product
Table 89. Salix Pharmaceuticals Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 90. Salix Pharmaceuticals Recent Development
Table 91. Gilead Sciences Inc. Company Details
Table 92. Gilead Sciences Inc. Business Overview
Table 93. Gilead Sciences Inc. Crohn’s Disease Therapeutics Product
Table 94. Gilead Sciences Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 95. Gilead Sciences Inc. Recent Development
Table 96. Genentech Inc. Company Details
Table 97. Genentech Inc. Business Overview
Table 98. Genentech Inc. Crohn’s Disease Therapeutics Product
Table 99. Genentech Inc. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Genentech Inc. Recent Development
Table 101. UCB India Private Limited. Company Details
Table 102. UCB India Private Limited. Business Overview
Table 103. UCB India Private Limited. Crohn’s Disease Therapeutics Product
Table 104. UCB India Private Limited. Revenue in Crohn’s Disease Therapeutics Business (2020-2025) & (US$ Million)
Table 105. UCB India Private Limited. Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Crohn’s Disease Therapeutics Picture
Figure 2. Global Crohn’s Disease Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Crohn’s Disease Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Non-Surgical Features
Figure 5. Surgical Features
Figure 6. Global Crohn’s Disease Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Crohn’s Disease Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Crohn’s Disease Therapeutics Report Years Considered
Figure 11. Global Crohn’s Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Crohn’s Disease Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Crohn’s Disease Therapeutics Market Share by Region: 2024 VS 2031
Figure 14. Global Crohn’s Disease Therapeutics Market Share by Players in 2024
Figure 15. Global Top Crohn’s Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crohn’s Disease Therapeutics as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Crohn’s Disease Therapeutics Revenue in 2024
Figure 17. North America Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 19. United States Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 23. Germany Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Crohn’s Disease Therapeutics Market Share by Region (2020-2031)
Figure 31. China Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 39. Mexico Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Crohn’s Disease Therapeutics Market Share by Country (2020-2031)
Figure 43. Turkey Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Crohn’s Disease Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Johnson and Johnson Services Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 47. Pfizer Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 48. Allergan Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 49. AbbVie Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 50. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 51. Celgene Corporation Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 52. Perrigo Company PLC Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 53. Ferring B.V. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 54. Salix Pharmaceuticals Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 55. Gilead Sciences Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 56. Genentech Inc. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 57. UCB India Private Limited. Revenue Growth Rate in Crohn’s Disease Therapeutics Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232